If you have been reading about Plasma half-life and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-02-19. Numbers and descriptions here follow the published literature rather than marketing material.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | Reverse-phase HPLC | Reported as area percentage |
| Identity confirmation | Mass spectrometry | Electrospray or laser desorption |
| Powder storage | Minus 20 degrees Celsius or lower | Dark and dry conditions |
| Solution storage | Two to eight degrees Celsius | Avoid repeated freeze-thaw |
| Appearance | White to off-white powder | Common lyophilized form |
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
=== January === 1 January – A driver runs over two police officers on a foot patrol in Nelson, killing one and injuring the other. A 32-year-old man is arrested. 3 January: A 32-year old man is charged with the murder of Nelson police officer Senior Sergeant Lyn Fleming. Biosecurity New Zealand launches a major biosecurity operation after an oriental fruit fly is detected in South Auckland. Thousands attend a vigil in Nelson for slain police officer Lyn Fleming. Air New Zealand flight NZ677 from Auckland to Dunedin is cancelled due to a phone threat, affecting 170 passengers. 4 January – Interislander and Bluebridge cancel a total of seven ferry crossings in response to rough weather conditions in the Cook Strait. 5 January – Interislander and Bluebridge cancel five ferry crossings in response to continuing rough weather in the Cook Strait. 6 January: The Desert Road closes for two months of repairs. Interislander and Bluebridge suspend ferry crossings due to rough weather in the Cook Strait. 8 January – Over 2,070 customers in the Kaipara District experience internet outages after a digger damages the main fibre optic cable between Whangārei and Dargaville. 9 January: In response to significant public interest, New Zealand Parliament's justice select committee extends the submission deadline for the Treaty Principles Bill to 1pm on 14 January. A fire engulfs 20 hectares (49 acres) of scrubland in Whangārei, leading to the evacuation of two houses.
==== Initial use ==== Moisture can cause mold and spoilage in many items. It can also damage electronics by causing condensation and shorten the lifespan of chemicals, like those in vitamins. Silica gel packets help by absorbing moisture and extending the life of these items. Silica gel may also be used to keep the relative humidity inside a high frequency radio or satellite transmission system waveguide as low as possible (see also humidity buffering). Excessive moisture buildup within a waveguide can cause arcing inside the waveguide itself, damaging the power amplifier feeding it. Also, the beads of water that form and condense inside the waveguide change the characteristic impedance and frequency, degrading the signal. It is common for a small compressed air system (similar to a small home aquarium pump) to be employed to circulate the air inside the waveguide over a jar of silica gel. Silica gel is also used to dry the air in industrial compressed air systems. Air from the compressor discharge flows through a bed of silica gel beads. The silica gel adsorbs moisture from the air, preventing damage at the point of use of the compressed air due to condensation or moisture. The same system is used to dry the compressed air on railway locomotives, where condensation and ice in the brake air pipes can lead to brake failure.
Serpins are a superfamily of proteins with similar structures that were first identified for their protease inhibition activity and are found in all kingdoms of life. The acronym serpin was originally coined because the first serpins to be identified act on chymotrypsin-like serine proteases (serine protease inhibitors). They are notable for their unusual mechanism of action, in which they irreversibly inhibit their target protease by undergoing a large conformational change to disrupt the target's active site. This contrasts with the more common competitive mechanism for protease inhibitors that bind to and block access to the protease active site. Protease inhibition by serpins controls an array of biological processes, including coagulation and inflammation, and consequently these proteins are the target of medical research. Their unique conformational change also makes them of interest to the structural biology and protein folding research communities. The conformational-change mechanism confers certain advantages, but it also has drawbacks: serpins are vulnerable to mutations that can result in serpinopathies such as protein misfolding and the formation of inactive long-chain polymers. Serpin polymerisation not only reduces the amount of active inhibitor, but also leads to accumulation of the polymers, causing cell death and organ failure.
This enabled them to make a number of major technological improvements, including the introduction of fiber suppressors (1981), a metal-free system eliminating sources of contamination and corrosion (1981), integrated workstation and process analysis capabilities (1984), suppressors for gradient elution (1986) and accelerated solvent extraction (1995). These technological changes made it possible for scientists to detect ionic materials quickly at extremely low levels of concentration. This increased both the sensitivity of the tests that it was possible to do and the productivity of the people doing them. Bowman recognized the importance of developing software and data handling capabilities in support of Dionex's hardware. Bowman has also emphasized the importance of marketing support, working closely with customers to ensure that they were satisfied with the products they were using, and developing new applications for customers' areas of interest. He has stated that, in his opinion, what distinguished Dionex was that "we do provide a complete solutions approach for our customers. We don't just sell them hardware and walk away. We work with them to make sure that what we sell them makes them more effective and productive in their job." Through such improvements, Dionex was able to support much faster extraction of organic compounds for analysis from chemical mixtures, including complicated samples such as soils, polymers, and processed foods.
== Further reading == Jenkins, Tiffany (2011). Contesting Human Remains in Museum Collections: the crisis of cultural authority. New York: Routledge. ISBN 9780415879606. Lohman, Jack; Goodnow, Katherine, eds. (2006). Human Remains & Museum Practice. Paris/London: UNESCO Publishing/Museum of London. ISBN 9789231040214. Graham, Shawn; Huffer, Damian (2020). "Reproducibility, Replicability, and Revisiting the Insta-Dead and the Human Remains Trade". Internet Archaeology (55). doi:10.11141/ia.55.11. The Bonetrade: Studying the online trade in human remains with machine learning and neural networks
Sources: en.wikipedia.org
Nuclides (or nucleides, from nucleus; also known as nuclear species) are a class of atoms characterized by their number of protons, Z, their number of neutrons, N, and their nuclear energy state. The word nuclide was coined by the American nuclear physicist Truman P. Kohman in 1947. Kohman defined nuclide as a "species of atom characterized by the constitution of its nucleus" containing a certain number of neutrons and protons. The term thus originally focused on the nucleus.
Meinrad Busslinger (born 30 July 1952) is a biochemist and immunologist, renown for his work on B cells. He is a Senior Scientist and Scientific Deputy Director of the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.
Luminol in an alkaline solution with hydrogen peroxide in the presence of iron or copper, or an auxiliary oxidant, produces 3-aminophtalate in an excited state, which exhibits chemiluminescence. The luminol reaction is
Richard Stephen Baldock. For services to the community in Over Wallop, Hampshire. Frank Keith Ball. Poppy Appeal Collector, Royal British Legion. For voluntary service to Veterans. Michael Lawrence Ballinger. For services to the community in Wickford and District, Essex. Sean Balmer. Coach, Cockermouth Swimming Club. For services to Swimming in Cumbria. Ian John Barnaby. Crew and Navigator, Torbay Lifeboat Station, Royal National Lifeboat Institution. For voluntary services to Maritime Safety. Robert Smart Barnes. Pipe Major, Methil and District Pipe Band. For services to Young People and to the community in Levenmouth, Fife. Wendy Angharad Barnett. Guide Leader. For services to Girlguiding and to the community in Milford Haven, Pembrokeshire. Elaine Phyllis Paterson Barnwell. Fundraiser, Royal Marines Association - The Royal Marines Charity. For Charitable Services. Dr. Michael Bartlett. Medical Educator, Hywel Dda Health Board and the Royal National Lifeboat Institution. For services to Medical Education. Kirstie Louise Baughan. Social Worker, Central Bedfordshire Council. For services to Social Work. Martin James Bazeley. For services to the community in Southwick, Hampshire. Valerie Beattie. For services to the community in County Antrim. Christine Ann Beech. Guide Leader, 1st Long Lawford Brownies, Warwickshire. For services to Young People. Andrew Colin Beevers. For services to Bell Ringing and to the community in Ecclesfield, South Yorkshire. Sheila May Betts. Chair and Volunteer, The Jarman Centre, Girlguiding Cambridgeshire East. For services to Young People.
In February 2015, Labcorp acquired Covance for $6.1 billion. In October 2015, Labcorp acquired Safe Foods International Holdings and its two operating companies, International Food Network and The National Food Laboratory, expanding its capabilities in food and beverage product-development and product-integrity. In March 2016, Labcorp acquired Pathology Inc., a provider of reproductive donor testing as well as anatomic, molecular and digital pathology services focused on women's health. In September 2016, Labcorp acquired Sequenom for $371 million including debt, expanding its operations in Europe and Asia. In October 2016, Labcorp acquired ClearPath Diagnostics, a provider of laboratory diagnostic services in the Northeastern United States, from Shore Capital Partners. In May 2017, Labcorp acquired Pathology Associates Medical Laboratories from Providence Health & Services and Catholic Health Initiatives. In September 2017, Labcorp acquired Chiltern, a contract research organization (CRO), for $1.2 billion, and contributed it to Covance. In 2019, Labcorp acquired Wellness Corporate Solutions, a workplace wellness company.
Sources: en.wikipedia.org
The powder is normally held at minus twenty degrees Celsius or below. Light and moisture exposure should be minimized. Repeated warming and cooling cycles are avoided.
Reverse-phase high-performance liquid chromatography is used for purity. Mass spectrometry confirms molecular weight and sequence integrity. Amino acid analysis offers an additional compositional check.
Published stability data for dissolved material are limited and vary with conditions. Refrigerated solutions are generally used within a short period. The exact shelf life depends on concentration, buffer, and handling.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.